09/22/09Coherex Medical Signs Exclusive Distribution Agreement with Abbott
09/22/09Coherex Medical Announces Lunch Symposium during TCT 2009(the Transcatheter Cardiovascular Therapeutics Conference) on Tues., Sept. 22, 2009
08/20/09Coherex Medical Closes $16.5 Million Series B Preferred Stock Financing
07/08/09Coherex Medical’s Coherex FlatStent EF PFO Closure System Granted CE Mark Clearance for Closing PFOs – a Common Heart Defect; Company to Begin Sales/Marketing Efforts in Europe
07/08/09CE Mark Clearance for Coherex Medical’s Coherex FlatStent EF PFO Closure System
10/13/08Chronic Migraines Caused by a Hole in the Heart? “Highly Likely,” New Research Says10/12/08Coherex Medical Announces Breakfast Symposium and Executive Presentations During This Week’s TCT 2008 (the Transcatheter Cardiovascular Techniques Conference)
10/21/07 First “Live Case” Transmission of a PFO Closure Procedure Using the Coherex FlatStent PFO Closure System to be Presented at TCT 2007
10/03/07Coherex Medical Successfully Completes First Human Cases with its Coherex FlatStent PFO Closure System as Company Begins COHEREX-EU Study to Seek CE Mark Clearance
10/03/07 Utah company's new stent may help repair heart defects
10/02/07 Coherex Medical to Begin its COHEREX-EU Study to Pursue CE Mark Clearance for its Coherex FlatStent PFO Closure System
10/01/07Coherex Medical has been invited to deliver a presentation at In3 East, Boston, one of the leading venture capital and strategic partnership conferences in the United States
05/10/072007 Utah Innovation Awards Winners
04/17/072007 Utah Innovation Awards Finalists
Notice: The Coherex device has been CE Marked and is available commercially outside of the USA. It is not available for investigational use or for commercial distribution at this time in the USA.
